A New Weight-Loss Drug Just Outperformed Popular GLP-1s. Here’s What It Means for the Future of Health
RSS SUMMARY · AGGREGATED FROM INC
Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
Continue Reading
The full story continues on Inc..
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
INC
Business
Apple’s New Ad Is a Brutal Jab at Google Chrome and Its Privacy Policies
INC·4h ago·3 min read
Business
After the Collapse of Spirit Airlines, This Major Budget Carrier Just Became the Target of a $4.1 Billion Takeover
INC·7h ago·3 min read
Business
How a Biotech Startup Is Using Dogs and AI to Rewrite the Rules of Cancer Screening
INC·7h ago·3 min read
Business
The Unicorn Trap: How a $1 Billion Valuation Just Became a Startup’s Worst Nightmare
INC·7h ago·3 min read
Related
On this beat
Business
Flesh-Eating Screwworm Found in Texas Calf, USDA Says
TWSJ·1h ago·3 min read
Business
Slumping Chinese oil imports ‘shield’ global market from higher prices
FT·1h ago·3 min read
Business
Flesh-Eating Pest Confirmed in U.S. Cattle
TNYT·2h ago·3 min read
Business
Pace Gallery Cuts 50 Artists and 50 Staff Amid Art Market Challenges
TNYT·1h ago·3 min read